FORM 4[__] Check this box if no longerUNITED STATES SECURITIES AND EXCHANGE COMMISSION
subject to Section 16. Form 4 or Form
5 obligations may continue.
See Instruction 1(b).
(Print or Type Responses)
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287Expires: January 31, 2005
Estimated average burden
hours per response. . . . . 0.51. Name and Address of Reporting Person*Samuelsson, Bengt(Last) (First) (Middle)
100 Route 206 North(Street)
Peapack, NJ 07977(City) (State) (Zip)
2. Issuer Name and Ticker
or Trading Symbol
Pharmacia - PHA3. I.R.S. Identification
Number of Reporting
Person, if an entity
(voluntary)
4. Statement for
(Month/Day/Year)
11/18/20025. If Amendment,
Date of Original
(Month/Day/Year)
6. Relationship of Reporting Person(s) to Issuer(Check all applicable)
X Director __ 10% Owner
__ Officer (give title below) __ Other (specify below)
7. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
____ Form filed by More than One Reporting PersonTable I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned1. Title of Security
(Instr. 3)
2. Transaction Date
(Month/Day/Year)2A. Deemed Execution Date, if any
(Month/Day/Year)3. Transaction Code
(Instr. 8)4. Securities Acquired (A) or
Disposed of (D)
(Instr. 3, 4, and 5)5. Amount of
Securities
Beneficially
Owned
Following Reported Transaction(s)
(Instr. 3 and 4)6. Ownership Form:
Direct (D) or
Indirect (I)
(Instr. 4)7. Nature of Indirect BeneficialCode V Amount (A) or (D) Price Common11/18/2002 S 3,800D45.175,000D
Ownership
(Instr. 4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities)1. Title of Derivative Security
(Instr. 3)2. Conver-
sion or
Exercise
Price of
Deri-
vative
Security3. Transaction
Date (Month/
Day/ Year)3A. Deemed
Execution Date,
if any (Month/
Day/ Year)4. Transaction Code
(Instr.8)5. Number of
Derivative
Securities Acquired
(A)
or Disposed of (D)
(Instr. 3, 4 and 5)6. Date Exercisable and
Expiration Date
(Month/Day/Year)7. Title and Amount
of Underlying
Securities
(Instr. 3 and 4)8. Price of
Derivative
Security
(Instr. 5)9. Number of
Derivative
Securities
Beneficially
Owned
Following
Reported
Transaction(s)
(Instr. 4)10. Ownership
Form of Derivative
Securities:
Direct (D)
or
Indirect (I)
(Instr. 4)11. Nature ofCode V (A) (D) Date
Indirect
Beneficial
Ownership
(Instr. 4)
Exercisable Expiration
Date Title Amount or
Number of
SharesExplanation of Responses:
/s/ Don W. Schimtz attorney-in-fact for Bengt Samuelsson 11/19/2002 ** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
See Instruction 6 for procedure.